{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:56:38Z","timestamp":1791435398469,"version":"4.3.3"},"reference-count":46,"publisher":"Impact Journals, LLC","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2024,6,15]]},"DOI":"10.18632\/aging.205880","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T16:11:14Z","timestamp":1717085474000},"page":"9498-9517","source":"Crossref","is-referenced-by-count":3,"title":["THY1 is a prognostic-related biomarker via mediating immune infiltration in lung squamous cell carcinoma (LUSC)"],"prefix":"10.18632","volume":"16","author":[{"given":"Changsheng","family":"Yi","sequence":"first","affiliation":[{"name":"The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou 450008, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zang","sequence":"additional","affiliation":[{"name":"Henan Provincial Chest Hospital, Zhengzhou University, Zhengzhou 450000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, First Affiliated Hospital, Shihezi University, Shihezi, Xinjiang 832000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1056\/NEJMra1703413","article-title":"Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer.","volume":"37","author":"Rabe","year":"2017","journal-title":"N Engl J Med"},{"key":"2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.6004\/jnccn.2013.0084","article-title":"Non-small cell lung cancer, version 2.2013.","volume":"1","author":"Jahan","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments.","volume":"38","author":"Paz-Ares","year":"2017","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/ncponc1187","article-title":"Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.","volume":"5","author":"Diamandis","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ijc.25047","article-title":"Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma.","volume":"12","author":"Lung","year":"2010","journal-title":"Int J Cancer"},{"key":"6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/s0301-472x(99)00010-7","article-title":"Adhesion molecules involved in the interactions between early T cells and mesenchymal bone marrow stromal cells.","volume":"2","author":"Zipori","year":"1999","journal-title":"Exp Hematol"},{"key":"7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1096\/fj.05-5460rev","article-title":"Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis.","volume":"2","author":"Hagood","year":"2006","journal-title":"FASEB J"},{"key":"8","doi-asserted-by":"publisher","first-page":"e76830","DOI":"10.1371\/journal.pone.0076830","article-title":"The expression of CD90\/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study.","volume":"8","author":"Tiribelli","year":"2013","journal-title":"PLoS One"},{"key":"9","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/modpathol.2010.122","article-title":"CD90\/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.","volume":"2","author":"Liu","year":"2010","journal-title":"Mod Pathol"},{"key":"10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/s0165-4608(02)00855-5","article-title":"THY1 expression is associated with tumor suppression of human ovarian cancer.","volume":"14","author":"Wang","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-4608(03)00234-6","article-title":"The role of the THY1 gene in human ovarian cancer suppression based on transfection studies.","volume":"14","author":"Wang","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"12","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1158\/0008-5472.CAN-15-3278","article-title":"DNA Methylation in Cancer and Aging.","volume":"7","author":"Cedar","year":"2016","journal-title":"Cancer Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","article-title":"Macrophage regulation of tumor responses to anticancer therapies.","volume":"2","author":"Lewis","year":"2013","journal-title":"Cancer Cell"},{"key":"14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment.","volume":"2","author":"Coussens","year":"2012","journal-title":"Cancer Cell"},{"key":"15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4065\/83.5.584","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.","volume":"8","author":"Adjei","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa031644","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.","volume":"35","author":"Vansteenkiste","year":"2004","journal-title":"N Engl J Med"},{"key":"17","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.","volume":"36","author":"Hirano","year":"2010","journal-title":"N Engl J Med"},{"key":"18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.","volume":"37","author":"Cho","year":"2018","journal-title":"N Engl J Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.","volume":"38","author":"Polikoff","year":"2017","journal-title":"Lancet"},{"key":"20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer.","volume":"1","author":"Weaver","year":"2014","journal-title":"EMBO Rep"},{"key":"21","doi-asserted-by":"publisher","first-page":"103696","DOI":"10.1016\/j.compbiomed.2020.103696","article-title":"Modeling of connective tissue damage for blunt dissection of brain tumor in neurosurgery simulation.","volume":"12","author":"Zheng","year":"2020","journal-title":"Comput Biol Med"},{"key":"22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1134\/s0006297908050052","article-title":"Reorganization of molecular morphology of epitheliocytes and connective-tissue cells in morphogenesis and carcinogenesis.","volume":"7","author":"Vasiliev","year":"2008","journal-title":"Biochemistry (Mosc)"},{"key":"23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10911-004-1404-x","article-title":"The tension mounts: mechanics meets morphogenesis and malignancy.","volume":"9","author":"Weaver","year":"2004","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"24","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/jcm8050642","article-title":"Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells.","volume":"8","author":"Chakrabarti","year":"2019","journal-title":"J Clin Med"},{"key":"25","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/0008-5472.CAN-12-0122","article-title":"Tumor microenvironment complexity: emerging roles in cancer therapy.","volume":"7","author":"DeClerck","year":"2012","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy.","volume":"2","author":"Anders","year":"2014","journal-title":"Clin Cancer Res"},{"key":"27","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis.","volume":"1","author":"Joyce","year":"2013","journal-title":"Nat Med"},{"key":"28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","article-title":"Lung cancer immunotherapy: progress, pitfalls, and promises.","volume":"2","author":"Paul","year":"2023","journal-title":"Mol Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"115891","DOI":"10.1016\/j.biopha.2023.115891","article-title":"Advances and challenges in the treatment of lung cancer.","volume":"16","author":"He","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"30","doi-asserted-by":"publisher","first-page":"823618","DOI":"10.3389\/fimmu.2022.823618","article-title":"Immunotherapy in Lung Cancer: Current Landscape and Future Directions.","volume":"1","author":"Jalal","year":"2022","journal-title":"Front Immunol"},{"key":"31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019.","volume":"6","author":"Jemal","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"32","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1016\/S1470-2045(16)30123-1","article-title":"Novel therapeutic targets on the horizon for lung cancer.","volume":"1","author":"Tan","year":"2016","journal-title":"Lancet Oncol"},{"key":"33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020.","volume":"7","author":"Jemal","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"34","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.","volume":"4","author":"Zhang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.","volume":"7","author":"Liu","year":"2017","journal-title":"Cancer Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1593\/neo.07112","article-title":"Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.","volume":"9","author":"Chinnaiyan","year":"2007","journal-title":"Neoplasia"},{"key":"37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform.","volume":"6","author":"Chinnaiyan","year":"2004","journal-title":"Neoplasia"},{"key":"38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1755-8794-2-18","article-title":"PrognoScan: a new database for meta-analysis of the prognostic value of genes.","volume":"2","author":"Sarai","year":"2009","journal-title":"BMC Med Genomics"},{"key":"39","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.","volume":"1","author":"Varambally","year":"2017","journal-title":"Neoplasia"},{"key":"40","doi-asserted-by":"publisher","first-page":"e82241","DOI":"10.1371\/journal.pone.0082241","article-title":"Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer.","volume":"8","author":"L\u00e1nczky","year":"2013","journal-title":"PLoS One"},{"key":"41","doi-asserted-by":"publisher","first-page":"W561","DOI":"10.1093\/nar\/gkz445","article-title":"MEXPRESS update 2019.","volume":"4","author":"De Meyer","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13072-015-0014-8","article-title":"Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer.","volume":"8","author":"Peinado","year":"2015","journal-title":"Epigenetics Chromatin"},{"key":"43","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: a web server for gene set cancer analysis.","volume":"3","author":"Guo","year":"2018","journal-title":"Bioinformatics"},{"key":"44","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types.","volume":"4","author":"Zhang","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"45","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible.","volume":"4","author":"von Mering","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"46","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1002\/pmic.201400515","article-title":"FunRich: An open access standalone functional enrichment and interaction network analysis tool.","volume":"1","author":"Stroud","year":"2015","journal-title":"Proteomics"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:51:00Z","timestamp":1718880660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.205880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,6,15]]}},"alternative-id":["205880","38819947"],"URL":"https:\/\/doi.org\/10.18632\/aging.205880","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}